Sahu evaluated percutaneous plantar fascia release under local anesthesia in 78 patients (13 male, 65 female; mean age 45 years) with plantar fasciitis unresponsive to β₯6 months of conservative treatment, following them for 1 year. Pain relief averaged 8 weeks postoperatively; 69/78 (88.46%) achieved 'excellent' and 9/78 (6.41%) 'good' results on the Grundberg and Dobson scale, with zero reported complications and universal return to work .
Note: 69+9=78, yet the text also states 9 patients were 'partially satisfied' while 6.41% was labeled 'good' β the excellent/good/poor classification arithmetic and satisfaction categories are not fully reconciled, a minor internal inconsistency.
A later nonrandomized comparative series (n=54) found percutaneous release achieved faster functional recovery than open fasciotomy on FADI scores at every timepoint, with far less numbness (5.9% vs 35%, p=0.007) . Notably, the Iraqi series reported some numbness complications even percutaneously, making Sahu's absolute zero-complication claim stand out as unusually favorable. Separately, a 2025 study found that preoperative steroid-injection response predicted better endoscopic release outcomes, suggesting patient-selection heterogeneity that Sahu did not stratify .
Simulated/illustrative comparison of reported complication rates; study populations and techniques differ (e.g., the Indian study did not measure FADI).
Reported strengths: clear inclusion/exclusion criteria, prospective design, 100% 1-year follow-up, and reproducible surgical technique description. Key weaknesses: no control group, no validated patient-reported outcome measures (no VAS, AOFAS, or FADI), unblinded single-surgeon assessment, a rating scale (Grundberg and Dobson) borrowed from tennis-elbow release literature, and no objective measurement of how much fascia was actually released β a parameter the author himself acknowledges is the key determinant of lateral-column complications . The zero-complication result may reflect short follow-up, subjective detection, or selective reporting. A 2026 study's alternative approach β calcaneal spur resection without fascial release β achieved VAS reduction from 79.6 to 5.3 mm (P<.001), challenging whether fascial release is even necessary in spur-associated cases . Falsification would require a randomized trial showing no pain-relief superiority over continued conservative care, or complication rates above zero in larger blinded cohorts .
Know what changed, what holds up, and what remains uncertain. Every Friday. No ads.